ArticleObesity surgery2026
First Case Series on Ambulatorial Endoscopic Sleeve Gastroplasty for Morbidity Obesity: A Single Center Experience.
Article in Obesity surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEndoscopic Sleeve Gastroplasty (ESG) is a minimally invasive endoscopic weight-loss procedure. Its outpatient application can reduce hospital stays and speed up recovery. The aim of this study is to compare ambulatory and hospitalized patients, identify predictors of hospitalization, and assess the safety and feasibility of outpatient ESG.
methodsFrom November 2016 to April 2025, we performed 430 ESG procedures, with 228 (53%) completed in an ambulatory setting and 202 (47%) requiring hospitalization. We retrospectively analysed demographic and procedural data. Continuous variables were compared by independent sample Kruskal-Wallis test, while categorical variables were analysed using Pearson's chi-squared test. Logistic regression model was used to identify predictors of hospitalization.
resultsThe cohort included 97 males (22.7%) and 333 females (77.4%), with a mean age of 43 years [IQR 33-52], mean weight of 108 kg [IQR 95-123], and a mean BMI of 38.67 [IQR 35.57-42.99]. The mean operative time was 29 min [IQR 24-37]. Comparative analyses between ambulatory and hospitalized patients are summarized in Table 1, identifying age, BMI, general anaesthesia, and ASA class as predictors of hospitalization. Among the 228 ambulatory patients, 9 (4%) required unplanned postoperative admission. These patients demonstrated lower Chung scores at reassessment, primarily due to nausea and pain. No differences were observed in preoperative variables.
conclusionAmbulatory ESG is a safe, effective, and efficient option for selected patients, with a low rate of post-procedure hospitalization, representing a promising approach in bariatric endoscopy.
Indexed as
Identifiers
42435269What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.